Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies LifeArc will make a US$30 million equity investment in KymabLifeArc to gain access to...

Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer Cambridge, UK; April 8, 2019: Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics,...